StromaCel

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameStromaCel

Drug Alias Namestromal stem cell therapy (Proteonomix)stromal stem cell therapy (National Stem Cell Holding)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Peripheral blood stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsMyocardial InfarctionHeart Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesProteonomix Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesProteonomix Inc

Active IndicationsN/A

Inactive IndicationsMyocardial InfarctionHeart Diseases

Other Information

ATC CodeN/A